MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$10,047K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Change in fair value of continge...
Depreciation and amortization ex...
Stock-based compensation
Others
Negative Cash Flow Breakdown
Net loss
Accounts payable and accrued lia...
Machinery and equipment purchase...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net revenue
-
-
-
260
Cost of revenues
-
-
-
112
Personnel-related expenses and board fees
-
-
-
3,329
Professional fees, legal, and outside services
-
-
-
3,094
Facilities and insurance
-
-
-
-837
Laboratory supplies and expenses
-
-
-
943
Marketing and advertising
-
-
-
97
Travel and entertainment
-
-
-
185
Other segment items
-
-
-
-98
Segment loss from operations
-
-
-8,666
-6,565
Depreciation and amortization expenses
-
-
563
584
Stock-based compensation
-
-
721
521
Change in fair value of contingent consideration
-
-5,918
-1,115
3,378
Impairment losses
-
-
14,600
-
Impairment loss on held for sale assets
-
-
0
0
Loss from operations
-
-
-
-11,048
Interest expense
-
-23
-26
-29
Other income, net
-
146
506
223
Income taxes
-
-
0
0
Net loss
-11,260
-4,290
-22,955
-10,854
Depreciation and amortization expense
665
631
563
584
Amortization of intangible assets
0
0
0
0
Stock-based compensation
661
615
721
521
Equity compensation for bonus awards and consulting services
8
32
38
38
Change in fair value of contingent consideration
2,284
-5,918
-1,115
3,378
Impairment losses
-
-
14,600
-
Impairment loss on held for sale assets
-
-
0
0
Unrealized foreign currency losses
-12
5
-15
-170
Accounts receivable
35
-971
870
-254
Inventories
-175
-64
-25
-222
Prepaid expenses and other assets
589
-449
102
-65
Accounts payable and accrued liabilities
-1,105
-105
3,555
1,177
Operating lease assets and liabilities
-84
-83
-20
-57
Net cash used in operating activities
-9,268
-7,639
-5,545
-4,502
Proceeds from sale of equipment
-
-
0
-
Machinery and equipment purchases, and construction in progress
779
613
1,479
1,050
Net cash used in investing activities
-779
-613
-1,479
-1,050
Proceeds from sale of common shares
0
26,024
0
0
Financing costs to issue common shares
185
1,183
0
0
Proceeds from sale of common shares under at-the-market transactions
-
-
0
0
Financing costs for at-the-market sales
-
-
0
0
Redemption of series a redeemable convertible preferred shares
-
-
0
0
Contingent consideration liability payments
-
-
2
-
Proceeds from exercise of stock options
10
-
-
-
Taxes paid related to net share settlement of stock-based awards
237
-
72
-
Repayment of financing lease obligations
152
143
178
120
Net cash provided by financing activities
-564
24,698
-252
-120
Effect of exchange rate changes on cash and cash equivalents
-16
-10
-15
-105
Net change in cash, cash equivalents and restricted cash
-10,627
16,436
-7,291
-5,777
Cash, cash equivalents and restricted cash, beginning
29,355
12,919
20,210
10,336
Cash, cash equivalents and restricted cash, ending
18,728
29,355
12,919
20,210
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net change in cash,
cash equivalents and...
-$10,627K
(-167.90%↓ Y/Y)
Change in fair value of
contingent consideration
$2,284K
(-37.99%↓ Y/Y)
Depreciation and
amortization expense
$665K
(-36.24%↓ Y/Y)
Stock-based compensation
$661K
(-32.34%↓ Y/Y)
Inventories
-$175K
(-161.84%↓ Y/Y)
Unrealized foreign
currency losses
-$12K
Equity compensation
for bonus awards and...
$8K
(-90.91%↓ Y/Y)
Proceeds from exercise of
stock options
$10K
Net cash used in
operating activities
-$9,268K
(23.64%↑ Y/Y)
Net cash used in
investing activities
-$779K
(-18.75%↓ Y/Y)
Net cash provided by
financing activities
-$564K
(-101.98%↓ Y/Y)
Effect of exchange rate
changes on cash and cash...
-$16K
Canceled cashflow
$3,805K
Canceled cashflow
$10K
Net loss
-$11,260K
(31.40%↑ Y/Y)
Machinery and equipment
purchases, and...
$779K
(18.75%↑ Y/Y)
Taxes paid related to
net share...
$237K
Financing costs to issue
common shares
$185K
(-62.01%↓ Y/Y)
Repayment of financing
lease obligations
$152K
(-28.30%↓ Y/Y)
Accounts payable and
accrued liabilities
-$1,105K
(47.03%↑ Y/Y)
Prepaid expenses and
other assets
$589K
(211.64%↑ Y/Y)
Operating lease assets and
liabilities
-$84K
(-29.23%↓ Y/Y)
Accounts receivable
$35K
(103.18%↑ Y/Y)
Buy us a coffee
Insight Molecular Diagnostics Inc. (IMDX)
Insight Molecular Diagnostics Inc. (IMDX)